Dr. Li is the Angiotech Associate Professor at the Faculty of Pharmaceutical Sciences, University of British Columbia. His research focuses on developing innovative drug delivery technologies to enhance drug targeting and therapy with a particular interest in prodrugs and lipid- and polymer-based nanoparticles. His research program has been supported by federal funding including Canadian Institutes of Health Research (CIHR) and Natural Sciences and Engineering Research Council of Canada (NSERC).
He has received many awards, including new investigator awards from CIHR, American Association of Pharmaceutical Scientists (AAPS), Canadian Society for Pharmaceutical Sciences (CSPS), Association of Faculties of Pharmacy in Canada (AFPC) and Prostate Cancer Foundation (PCF).
For an up-to-date list of publications by Dr. Li, please see Laboratory of Targeted Drug Delivery and Nanomedicine.